Main Logo
EMA
EMA Validates Application for CAR T-Cell Therapy After First-Line Treatment
Leah SherwoodAggressive B-Cell Lymphoma | November 22, 2022
The European Medicines Agency validated a type II variation for the extension of the indication for lisocabtagene maraleucel ...
Read More
EMA Recommends Conditional Approval of Mosunetuzumab for Follicular Lymphoma
Kerri FitzgeraldAggressive B-Cell Lymphoma | November 14, 2022
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use recommended the conditional approval ...
Read More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Editorial Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    Formedics logo© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |